Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MEXP-3711

ABSTRACT: Transcription profiling of plasma cells and plasmablasts from patients with primary immune thrombocytopenia after rituximab treatment compared to treatment nave patients or healthy donors

PROVIDER: E-MEXP-3711 | ExpressionAtlas | 2025-01-22

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MEXP-3711-analysis-methods.tsv	Tabular
	E-MEXP-3711-atlasExperimentSummary.Rdata	Rdata
	E-MEXP-3711-configuration.xml	Xml
	E-MEXP-3711-percentile-ranks.tsv	Tabular
	E-MEXP-3711.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 67

Similar Datasets

E-MTAB-9397

Project description:Osteoblast primary cell lines (OBS) from Shwachman-Diamond Syndrome (SDS) patients compared to healthy donors by one color transciptome array

2025-01-23 | E-MTAB-9397 | ExpressionAtlas

E-MTAB-6491

Project description:Transcriptional profiling of primary human alveolar macrophages challenged with Streptococcus pneumoniae from patients with chronic obstructive pulmonary disease compared to healthy donors

2025-01-23 | E-MTAB-6491 | ExpressionAtlas

E-MEXP-1635

Project description:Transcription profiling by array of human PBMCs from primary antiphospholipid syndrome and systemic lupus erythematosus patients and healthy controls

2025-01-22 | E-MEXP-1635 | ExpressionAtlas

E-MTAB-4660

Project description:Transcription profiling of human blood eosinophils in eosinophilic asthma patients compared to healthy individuals

2025-01-23 | E-MTAB-4660 | ExpressionAtlas

E-GEOD-38616

Project description:Transcription profiling of primary oral mucosa from oral lichen planus patients and healthy individuals

2025-01-24 | E-GEOD-38616 | ExpressionAtlas

E-GEOD-36765

Project description:Gene expression profiling of CD4+ T cells from primary tumors, axillary lymph nodes and peripheral blood of 10 patients with invasive breast carcinomas and blood of 4 healthy donors

2025-01-24 | E-GEOD-36765 | ExpressionAtlas

RNA-seq of peripheral blood mononuclear cell (PBMC) derived from normal healthy donors and multiple myeloma (MM) patients

Project description:Multiple myeloma (MM), also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. There is no cure for MM. In addition, the mechanism underlying abnormal production of plasma cells is not clear. In this experiment, peripheral blood was obtained from normal healthy donors and multiple myeloma (MM) patients. Peripheral blood mononuclear cells (PBMC) were separated by Ficoll separation solution. Samples of four donors were pooled and Samples of four MM patients were pooled. The aim was to characterize the mRNA profile of MM patients compared to healthy donors and find the new target of diagnosis or treatment for MM.

2020-08-14 | E-MTAB-7146 | biostudies-arrayexpress

E-GEOD-93624

Project description:RNA-seq of 210 treatment-nave patients of pediatric Crohn's disease and 35 non-IBD controls from the RISK study

2019-05-14 | E-GEOD-93624 | ExpressionAtlas

Project description:Healthy donors and patients with primary immune thrombocytopenia Raw sequence reads

| PRJNA516023 | ENA

The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples

Project description:MicroRNAs are small regulatory RNAs that are deregulated in a wide variety of human cancers, including different types of B-cell lymphoma. Nevertheless, the feasibility of circulating microRNA for early diagnosis of B-cell lymphoma has not been established. To address the possibility of detecting specific circulating microRNAs years before a B-cell lymphoma is diagnosed, we studied the plasma expression of microRNA first in pre-treatment samples from patients with diffuse large B-cell lymphoma and subsequently in repository samples from blood donors who later developed B-cell lymphomas. In addition, we studied the microRNA expression in the diagnostic lymphoma biopsy and in plasma samples taken after end of treatment. The most strongly induced (miR-326) and suppressed (miR-375) plasma microRNA at diagnosis, when compared with healthy blood donors, were also substantially up- or down-regulated in plasma repository samples taken from several months to up to two years before the blood donors were diagnosed with B-cell lymphoma. Importantly, at these time points the donors had no signs of disease and felt healthy enough to donate blood. In conclusion, this first study of plasma microRNA profiles from apparently healthy individuals, taken several years before B-cell lymphoma diagnosis, suggests that plasma microRNA profiles may be predictive of lymphoma development.

2018-07-14 | GSE117063 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data